by AIP Online Bureau | Jul 23, 2024 | Health, Indian News, Policy
The three drugs are Trastuzumab deruxtecan, Osimertinib and Durvalumab. The reduction in customs duty may help reduce the financial burden on those battling the deadly disease New Delhi: In a big relief to cancer patients, Union Finance Minister Nirmala Sitharaman,...
by AIP Online Bureau | Jul 3, 2024 | Data, Health, Regulation
“Use of an excess amount of artificial food colours and flavouring agents to make the dish look more appealing and increase palatability carries various health risks, especially in those who frequently indulge in outside food,” Edwina Raj, Head of Services –...
by AIP Online Bureau | Jun 18, 2024 | Eco/Invest/Demography, Health, International News
The suit is the latest salvo in the ongoing legal battle between J&J and former talc users, who allege the world’s largest maker of health-care products hid the cancer risks of its iconic baby powder for almost half a century. J&J is seeking the backing from...
by AIP Online Bureau | Apr 23, 2024 | Health, International News, Regulation
But the relatively modest settlement should please Sanofi investors, who’ve worried in the past about the financial fallout of thousands of US lawsuits targeting Zantac makers such as Sanofi and GSK Plc, which originally developed the product Zantac was recalled in...
by AIP Online Bureau | Mar 28, 2024 | Data, Eco/Invest/Demography, Health, Technology
Sharing the reason behind starting this helpline number, he said there is been a rapid increase in the number of cancer cases in India and there is a dearth of healthcare facilities and healthcare doctors. In the rapidly evolving field of cancer treatment, where new...
